☆ 4.6 Review

Strategies Tackling Viral Replication and Inflammatory Pathways as Early Pharmacological Treatment for SARS-CoV-2 Infection: Any Potential Role for Ketoprofen Lysine Salt?

MOLECULES (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Infectious Diseases

Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents

Norberto Perico et al.

Summary: COVID-19 exhibits varying degrees of symptom severity, requiring different levels of care at different stages of the disease. Intervening early with anti-inflammatory drugs, especially NSAIDs, in the outpatient setting could prevent disease progression and long-term complications. Observational studies have shown promising results regarding the use of NSAIDs for early outpatient treatment of COVID-19.

LANCET INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Medicine, General & Internal

Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection A Randomized Clinical Trial

Meagan P. O'Brien et al.

Summary: This study evaluated the effect of subcutaneous casirivimab and imdevimab on progression from asymptomatic SARS-CoV-2 infection to symptomatic COVID-19. The results showed that this combination treatment significantly reduced the incidence of symptomatic COVID-19, as well as the duration of symptoms and viral load.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Medicine, General & Internal

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

A. Jayk Bernal et al.

Summary: This study found that early treatment with molnupiravir reduced the risk of hospitalization or death in at-risk, unvaccinated adults with Covid-19.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

Jennifer Hammond et al.

Summary: In high-risk, unvaccinated adults, treatment of Covid-19 with nirmatrelvir plus ritonavir can significantly reduce the risk of hospitalization and death, with good safety profile.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

In silico study of potential antiviral activity of copper(II) complexes with non-steroidal anti-inflammatory drugs on various SARS-CoV-2 target proteins

Elena G. Geromichalou et al.

Summary: This study investigated the interactions between non-steroidal anti-inflammatory drugs and copper complexes, as well as their potential as antiviral agents against SARS-CoV-2. Cytotoxic activity on human cell lines was also evaluated.

JOURNAL OF INORGANIC BIOCHEMISTRY (2022)

添加到收藏夹

Article Cell Biology

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Kathryn Westendorf et al.

Summary: A monoclonal antibody named LY-CoV1404 has been successfully isolated, which demonstrates highly potent neutralization against multiple variants of the SARS-CoV-2 virus. The binding site of LY-CoV1404 remains relatively conserved, allowing it to maintain its activity. This finding suggests that LY-CoV1404 has the potential to be an effective therapeutic agent against all known variants.

CELL REPORTS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

An overview of possible pivotal mechanisms of Genistein as a potential phytochemical against SARS-CoV-2 infection: A hypothesis

Abbas Jafari et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 is a global problem, and efforts are being made to find effective therapies. Genistein, a compound found in soy and plants, has been known for its anti-cancer, anti-inflammatory, and antioxidant effects. Scientific evidence suggests that genistein may have a potential role in treating COVID-19 and interfering with viral entry into cells.

JOURNAL OF FOOD BIOCHEMISTRY (2022)

添加到收藏夹

Article Biology

Effects of Different Corticosteroid Doses in Elderly Unvaccinated Patients with Severe to Critical COVID-19

Filippo Scialo et al.

Summary: SARS-CoV-2 infection can lead to a variety of clinical symptoms, with severe cases characterized by an uncontrolled inflammatory response. Elevated levels of certain proinflammatory cytokines are associated with severe COVID-19. The use of dexamethasone has become a standard treatment, but the optimal dose is still unknown. In this study, a higher dose of prednisone was associated with a longer time to negative swab and increased risk of adverse events. BMI, WBC number, and NLR value were directly related to death.

LIFE-BASEL (2022)

添加到收藏夹

Review Biology

Mucolytic and Antioxidant Properties of Carbocysteine as a Strategy in COVID-19 Therapy

Andrea Bianco et al.

Summary: Carbocysteine, a mucolytic agent with antioxidant and anti-inflammatory activities, has shown anti-viral effects on various viruses and can interfere with viral spread in the upper airway. In the treatment of COVID-19, Carbocysteine can be considered for post-exposure prophylaxis and early-phase treatment, in combination with other agents.

LIFE-BASEL (2022)

添加到收藏夹

Article Biology

Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients

Vito D'Agnano et al.

Summary: Serum KL-6 is significantly associated with the risk of death or intubation in severe to critical COVID-19 patients.

LIFE-BASEL (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Prevalence of NSAID use among people with COVID-19 and the association with COVID-19-related outcomes: Systematic review and meta-analysis

Huilei Zhao et al.

Summary: According to current evidence, the use of NSAIDs prior to admission or diagnosis of COVID-19 is not associated with an increased risk of COVID-19 and may even provide a survival benefit. However, controlled trials are needed to further evaluate the clinical benefit and safety of NSAIDs in treating patients with COVID-19.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

添加到收藏夹

Article Critical Care Medicine

Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase atrial

Thomas L. Holland et al.

Summary: This study compared the efficacy of tixagevimab-cilgavimab with placebo in hospitalized COVID-19 patients receiving remdesivir and standard care. The results showed that tixagevimab-cilgavimab did not improve sustained recovery, but it was safe and associated with lower mortality.

LANCET RESPIRATORY MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis

Qi Zhou et al.

Summary: This study found that the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, aspirin, and COX-2 inhibitor, did not increase the risk of adverse outcomes in patients with COVID-19. However, more research is needed to validate these findings due to the limited number of studies and low-quality evidence.

ECLINICALMEDICINE (2022)

添加到收藏夹

Review Cell Biology

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection

Yu-Chyi Hwang et al.

Summary: The COVID-19 pandemic has created a public health crisis, leading to the urgent development of therapeutic treatments and virus detection methods. Monoclonal antibodies (mAbs) have emerged as powerful tools for treating and detecting diseases due to their high specificity and reliability. Researchers are urgently developing antibody-based kits for SARS-CoV-2 detection and antibody drugs for COVID-19 treatment. The spike protein of SARS-CoV-2, which is crucial for viral infection, has been extensively studied and its receptor-binding domain (RBD) has become a major target for therapeutic antibody development. Given the high mutation rate of SARS-CoV-2, especially under the pressure of prophylactic vaccines and neutralizing antibodies, the use of antibody cocktails is expected to be an important strategy for effective COVID-19 treatment. Additionally, antibodies against cytokine storms, which can be triggered by SARS-CoV-2 infection and drive severe disease progression, are also being developed as treatments for COVID-19. In addition to their use as drugs, antibodies are currently being used in SARS-CoV-2 detection tests, including antigen and immunoglobulin tests, which are crucial surveillance tools for preventing the spread of COVID-19.

JOURNAL OF BIOMEDICAL SCIENCE (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Anticoagulant treatment in COVID-19: a narrative review

Vincenzo Carfora et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 often results in endothelial dysfunction, cytokine storm, and complement activation, leading to a pro-coagulative state and microvascular thrombi. The severity of thrombotic risk is directly linked to disease severity and prognosis, highlighting the importance of understanding the underlying mechanisms for effective treatment strategies.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes

Mina T. Kelleni

Summary: This manuscript presents a novel theory for the pathogenesis of COVID-19 and suggests the early use of NSAIDs, including ibuprofen, as a safe and potentially preventative measure for COVID-19 complications. The author also advocates against routine use of glucocorticoids for COVID-19 patients, recommending their use only for those with late acute respiratory distress syndrome.

BIOMEDICINE & PHARMACOTHERAPY (2021)

添加到收藏夹

Article Virology

Nonsteroidal Anti-inflammatory Drugs Dampen the Cytokine and Antibody Response to SARS-CoV-2 Infection

Jennifer S. Chen et al.

Summary: Research has shown that nonsteroidal anti-inflammatory drugs (NSAIDs) reduce the inflammatory response and antibody production in SARS-CoV-2 infection treatment, without affecting susceptibility to infection or viral replication.

JOURNAL OF VIROLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir

Goran Kokic et al.

Summary: Remdesivir is the only FDA-approved drug for treating COVID-19 patients, working by inhibiting the RNA-dependent RNA polymerase (RdRp) of coronaviruses. It hinders RNA synthesis and impairs proofreading by the viral 3'-exonuclease, leading to a stalled replication process.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Review Microbiology

A Comprehensive Review of Detection Methods for SARS-CoV-2

Aziz Eftekhari et al.

Summary: This paper summarizes promising methods for diagnosing SARS-CoV-2 infection, discussing the principles, advantages, and disadvantages of various techniques, and highlighting potential approaches for developing additional techniques for early and fast detection of SARS-CoV-2.

MICROORGANISMS (2021)

添加到收藏夹

Article Medicine, General & Internal

Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab

Anil Gupta et al.

Summary: In this study, among nonhospitalized patients with symptomatic Covid-19, sotrovimab treatment significantly reduced the risk of disease progression leading to hospitalization or death compared to placebo. Patients receiving sotrovimab also had a lower rate of serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Anesthesiology

Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials

Laura Pasin et al.

Summary: The efficacy and safety of corticosteroids in patients with COVID-19 are still debated. Recent trials have shown that corticosteroids may be beneficial for severely ill patients but should be discouraged in those not requiring oxygen therapy. Further clinical trials are needed before widespread implementation of this treatment.

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives

Hamid Rashidzadeh et al.

Summary: COVID-19, an emerging infectious disease, has caused significant impact on global health. Nanotechnology offers promising tools for designing effective diagnostic and therapeutic agents against the virus, showing potential in disease management.

NANOMEDICINE (2021)

添加到收藏夹

Article Critical Care Medicine

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Phillip D. Monk et al.

Summary: The study evaluated the efficacy and safety of using interferon beta-1a to treat COVID-19, with results showing that patients who received treatment had higher and faster recovery rates, providing potential evidence for further clinical trials.

LANCET RESPIRATORY MEDICINE (2021)

添加到收藏夹

Editorial Material Infectious Diseases

Corticosteroids prescription for mild-moderate COVID-19 in Primary Care

Alberto Ordinola Navarro et al.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2021)

添加到收藏夹

Review Clinical Neurology

Comparison of Efficacy of Ketoprofen and Ibuprofen in Treating Pain in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

Fabiola Atzeni et al.

Summary: A new meta-analysis comparing ketoprofen and ibuprofen in patients with RA found that ketoprofen was more effective in managing RA pain at therapeutic doses. There were no significant differences between the two drugs in terms of tolerability or safety based on the studies included in the meta-analysis.

PAIN AND THERAPY (2021)

添加到收藏夹

Article Medicine, General & Internal

Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial

Nicole Ezer et al.

Summary: The study aimed to determine if inhaled and intranasal ciclesonide were better than placebo in reducing respiratory symptoms in adult outpatients with covid-19. Results showed that there were no significant differences in symptom resolution between the intervention group receiving ciclesonide and the control group.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

COVID-19 and Cardiovascular Disease From Bench to Bedside

Mina K. Chung et al.

Summary: COVID-19, caused by SARS-CoV-2, has potential consequences on the cardiovascular health of millions of survivors worldwide. The virus can infect the heart, vascular tissues, and circulating cells through ACE2, leading to acute cardiac injury. This update reviews clinical manifestations, impact mechanisms, and management implications for patients after recovering from acute COVID-19 infection.

CIRCULATION RESEARCH (2021)

添加到收藏夹

Article Infectious Diseases

Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study

Lars Christian Lund et al.

Summary: This study examined prescription drug and healthcare utilization among individuals in Denmark who tested positive for SARS-CoV-2 but did not require hospital admission. The study found that these individuals had a low risk of severe post-acute complications, but showed increases in visits to general practitioners and outpatient hospital visits, indicating potential COVID-19 sequelae.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Critical Care Medicine

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Sanjay Ramakrishnan et al.

Summary: The study found that early administration of inhaled budesonide reduced the likelihood of needing urgent medical care and accelerated recovery time in patients with early COVID-19.

LANCET RESPIRATORY MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Ly-Mee Yu et al.

Summary: The study found that inhaled budesonide can reduce recovery time and potentially decrease the risk of hospital admissions or deaths among high-risk COVID-19 patients in the community.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

M. Dougan et al.

Summary: In this phase 3 trial, the combination of bamlanivimab plus etesevimab was found to reduce the incidence of Covid-19-related hospitalization and death among high-risk ambulatory patients compared to placebo, and also accelerated the decline in SARS-CoV-2 viral load.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants

Filippo Scialo et al.

Summary: The COVID-19 pandemic has had a significant impact on socio-economic life, especially posing higher risks for individuals with underlying health conditions. Despite year-long efforts in academic research, there is still much to learn about SARS-CoV-2 and its potential future impacts on human health.

BIOMEDICINES (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients

Paola Canzano et al.

Summary: The authors suggest that the cytokine storm in COVID-19 patients can lead to sustained cell-based activation of coagulation and altered platelet activity, which can be intervened through prophylactic anticoagulant treatment.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)

添加到收藏夹

Review Medicine, General & Internal

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

Paolo Verdecchia et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)

添加到收藏夹

Letter Hematology

Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?

Marco Cattaneo et al.

THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Potential Effects of Coronaviruses on the Cardiovascular System A Review

Mohammad Madjid et al.

JAMA CARDIOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Viral and host factors related to the clinical outcome of COVID-19

Xiaonan Zhang et al.

NATURE (2020)

添加到收藏夹

Article Medicine, General & Internal

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19

B. Cao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Review Respiratory System

Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis

Syed Shahzad Hasan et al.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2020)

添加到收藏夹

Letter Medicine, General & Internal

Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)

Pierre Francois Laterre et al.

JAMA NETWORK OPEN (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

Masataka Nishiga et al.

NATURE REVIEWS CARDIOLOGY (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?

Fabio Perrotta et al.

RESPIRATORY MEDICINE (2020)

添加到收藏夹

Review Immunology

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis

Andrew G. Harrison et al.

TRENDS IN IMMUNOLOGY (2020)

添加到收藏夹

Review Respiratory System

Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis

Ricardo J. Jose et al.

EUROPEAN RESPIRATORY REVIEW (2020)

添加到收藏夹

Review Endocrinology & Metabolism

Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways

Ersilia Nigro et al.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)

添加到收藏夹

Review Cell Biology

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2

Ma'mon M. Hatmal et al.

CELLS (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome

Jiao Liu et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

添加到收藏夹

Article Cell Biology

Aprotinin Inhibits SARS-CoV-2 Replication

Denisa Bojkova et al.

CELLS (2020)

添加到收藏夹

Review Respiratory System

ACE2: The Major Cell Entry Receptor for SARS-CoV-2

Filippo Scialo et al.

LUNG (2020)

添加到收藏夹

Review Geriatrics & Gerontology

COVID-19 and the elderly: insights into pathogenesis and clinical decision-making

Fabio Perrotta et al.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2020)

添加到收藏夹

Review Respiratory System

COVID-19 and coagulative axis: review of emerging aspects in a novel disease

Matilde Boccia et al.

MONALDI ARCHIVES FOR CHEST DISEASE (2020)

添加到收藏夹

Article Respiratory System

Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China

Yafei Wang et al.

RESPIRATION (2020)

添加到收藏夹

Article Critical Care Medicine

Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study

Felix Carl Fabian Schmitt et al.

ANNALS OF INTENSIVE CARE (2019)

添加到收藏夹

Review Medicine, Research & Experimental

Towards an Effective and Safe Treatment of Inflammatory Pain: A Delphi-Guided Expert Consensus

Giustino Varrassi et al.

ADVANCES IN THERAPY (2019)

添加到收藏夹

Article Cell Biology

Differential protein modulation by ketoprofen and ibuprofen underlines different cellular response by gastric epithelium

Laura Brandolini et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2018)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Host-directed therapies for bacterial and viral infections

Stefan H. E. Kaufmann et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

添加到收藏夹

Review Physiology

THE ACE2/ANGIOTENSIN-(1-7)/MAS AXIS OF THE RENIN-ANGIOTENSIN SYSTEM: FOCUS ON ANGIOTENSIN-(1-7)

Robson Augusto Souza Santos et al.

PHYSIOLOGICAL REVIEWS (2018)

添加到收藏夹

Review Pediatrics

The Role of Inflammation in Venous Thromboembolism

Brian R. Branchford et al.

FRONTIERS IN PEDIATRICS (2018)

添加到收藏夹

Article Microbiology

Toll-like receptor 4 in acute viral infection: Too much of a good thing

Judith Olejnik et al.

PLOS PATHOGENS (2018)

添加到收藏夹

Article Immunology

Recognition of Viral RNA by Pattern Recognition Receptors in the Induction of Innate Immunity and Excessive Inflammation During Respiratory Viral Infections

Masaaki Okamoto et al.

VIRAL IMMUNOLOGY (2017)

添加到收藏夹

Review Virology

Structure, Function, and Evolution of Coronavirus Spike Proteins

Fang Li

ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)

添加到收藏夹

Article Cell Biology

Gastroprotective Effects of L-Lysine Salification of Ketoprofen in Ethanol-Injured Gastric Mucosa

Annamaria Cimini et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2015)

添加到收藏夹

Article Pharmacology & Pharmacy

Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets

Aaruni Saxena et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2013)

添加到收藏夹

Article Hematology

High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs - pharmacological mechanisms and clinical relevance

Thomas Hohlfeld et al.

THROMBOSIS AND HAEMOSTASIS (2013)

添加到收藏夹

Review Immunology

Regulation of Immune Responses by Prostaglandin E-2

Pawel Kalinski

JOURNAL OF IMMUNOLOGY (2012)

添加到收藏夹

Article Immunology

IL-7 Restores Lymphocyte Functions in Septic Patients

Fabienne Venet et al.

JOURNAL OF IMMUNOLOGY (2012)

添加到收藏夹

Review Cell Biology

PGI2 as a Regulator of Inflammatory Diseases

Stacy L. Dorris et al.

MEDIATORS OF INFLAMMATION (2012)

添加到收藏夹

Article Immunology

Novel splice variants of human IKK epsilon negatively regulate IKK epsilon-induced IRF3 and NF-kB activation

Anja Koop et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2011)

添加到收藏夹

Article Virology

Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response

Ilona Glowacka et al.

JOURNAL OF VIROLOGY (2011)

添加到收藏夹

Article Virology

Receptor Tyrosine Kinase Inhibitors Block Multiple Steps of Influenza A Virus Replication

Naveen Kumar et al.

JOURNAL OF VIROLOGY (2011)

添加到收藏夹

Review Biochemistry & Molecular Biology

Epigenetic reprogramming of host genes in viral and microbial pathogenesis

Konstantinos Paschos et al.

TRENDS IN MICROBIOLOGY (2010)

添加到收藏夹

Review Neurosciences

Corticosteroids: way upstream

Therese Riedemann et al.

MOLECULAR BRAIN (2010)

添加到收藏夹

Review Physiology

The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice

Yumiko Imai et al.

EXPERIMENTAL PHYSIOLOGY (2008)

添加到收藏夹

Review Cell Biology

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

Puja K. Mehta et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)

添加到收藏夹

Review Medicine, General & Internal

Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase

Patricia McGettigan et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

添加到收藏夹

Article Immunology

Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates

SJ Liu et al.

VACCINE (2006)

添加到收藏夹

Article Biochemistry & Molecular Biology

Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein

Xiaohong Yan et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)

添加到收藏夹

Article Pharmacology & Pharmacy

Evidence for a central mechanism of action of S-(+)-ketoprofen

MI Díaz-Reval et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2004)

添加到收藏夹

Article Medicine, General & Internal

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.

F Catella-Lawson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

添加到收藏夹

Article Medicine, General & Internal

Comparison of the effects of ketoprofen on platelet function in the presence and absence of aspirin

RM Van Solingen et al.

AMERICAN JOURNAL OF MEDICINE (2001)

添加到收藏夹

Article Anesthesiology

Differential effects of spinal (R)-ketoprofen and (S)-ketoprofen against signs of neuropathic pain and tonic nociception: evidence for a novel mechanism of action of (R)-ketoprofen against tactile allodynia

MH Ossipov et al.

PAIN (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.